You Might Also Be
Interested In

Latham is distinguished by its “strong profile for complex patent litigation,” “expertise in Hatch-Waxman proceedings.”

Chambers USA 2020

Life Sciences IP Litigation

Latham’s award-winning life sciences IP practice works at the cutting edge of pharmaceutical and biotechnology patent, trade secrets, and brand-on-brand competitor litigation.

Molecular Structure

We offer life sciences companies a deep bench of patent litigators, many of whom hold advanced degrees in chemical or life sciences, as well as a team of PhD-holding technical analysts and former Federal Circuit clerks with significant experience litigating pharmaceutical cases. Our representations of innovator companies begin with us analyzing client patents and mastering the underlying science. Our lawyers and analysts are well-versed in all forms of life sciences patent and trade secrets litigation, from brand-on-brand biologic disputes, to matters involving vaccines, biosimilars, CRISPR, CAR-T, gene therapy, and diagnostics and manufacturing processes.

Hatch-Waxman Litigation

We represent many of the world’s leading innovative pharmaceutical companies in Hatch-Waxman litigation, regularly enforcing and defending patents that protect products with billions of dollars in annual sales.

Patent challenges by generic drug manufacturers are a persistent issue for branded pharmaceutical companies. We bring extensive experience preparing for and defending against these challenges. We understand the strategic and tactical implications that are particular to Abbreviated New Drug Application (ANDA) cases and use this knowledge to protect clients’ market opportunities, including in relation to pre-suit investigations, FDA strategy and related litigation, Patent Office proceedings, District Court litigations, and appeals. We leverage our extensive ANDA litigation experience with to develop a case that accounts for multiple challengers presenting multiple theories.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.